Prolacta Bioscience is a privately-held life sciences company dedicated to Advancing the Science of Human Milk to bring the healing power of breast milk to the most critically ill infants in neonatal care. Prolactas human milk-based neonatal nutritional products are changing the standard of care for preemies in hospitals nationwide.

Prolacta Bioscience, Inc. (Prolacta) is the pioneer in standardized human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a privately held, for-profit and scientifically driven company, committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Mothers who have a surplus of breast milk can help save the countrys most fragile infants by donating their extra breast milk through one of Prolactas affiliate milk banks.